Selected Publications and Presentations
Canada Consumer Product Safety Act Aims to Strengthen Product Safety Laws
Westlaw Journal: Products Liability, vol 22, issue 5
|
June 2011
Ontario Companies Doing Business with Hospitals May Become Subject to Access-to-Information Requests
Westlaw Journal: Medical Devices, vol. 18, issue 8
|
June 2011
Also published in Electronic Healthcare Law Review, vol. 1, no. 1
Canada Amends Regulations on Adverse Drug Reaction Reporting
Food and Drug Regulatory Bulletin
|
March 11, 2011
Ontario Government Seeks Appeal of Pharmacies’ Successful Challenge on Private Label Restrictions
Food and Drug Regulatory Bulletin
|
February 24, 2011
Patents and Patent Litigation
Lecturer, University of Waterloo, School of Pharmacy
|
June 14, 2010
Drafting Rights, Obligations, Exclusion and Limitation Clauses Workshop
Co-leader, Federated Press's Essentials of Commercial Contracts Course
|
May 27, 2010
Canada's Approach to Functional Foods
Update magazine, Issue 2
|
March/April 2010
With permission from FDLI
Reprinted in Health Law in Canada, Nov. 2011, vol. 32, no. 2
Introduction to Patents
Lecturer, York University, Schulich School of Business
|
March 23, 2010
Introduction to Intellectual Property and Regulatory Issues for Drug Products in Canada
Lecturer, University of Waterloo, School of Pharmacy (Health Sciences)
|
March 22, 2010 and March 28, 2011
CIPO's New Draft Guidelines Could Result in Higher Disclosure Standards for Canadian Patents
Intellectual Property Bulletin
|
November 25, 2009
Canada Proposes Amendments to Adverse Drug Reaction Reporting
Reproduced with permission of the publisher from Health Law in Canada, vol. 30, no. 1
|
October 2009
Biosimilars in Canada: New Draft Guidelines from Health Canada
Update magazine, Issue 4
|
July/August 2009
With permission from FDLI
Cited in Canadian Pharmacists Journal
8th Edition Drug Patent and Legal Forum
Speaker, St. Andrews Club & Conference Centre, Toronto
|
May 28 - 29 2009
Data Protection for "Innovative Drugs" – Guidance Now Final
Torys Food and Drug Regulatory Bulletin
|
April 2, 2009
Republished in Health Law in Canada, vol. 29, no. 3, May 2009
Direct to Physician Advertising: Addressing Legal and Compliance Issues in Direct to Physician Advertising, Grants and Sponsorships to Improve Adherence Rates
Presenter, 4th Annual Patient Adherence & Compliance Techniques, Toronto
|
November 7, 2008
Follow-on Biologics in Canada: A Look at the New Draft Guidelines
This article originally appeared in Update, issue 3. Reprinted with permission of the Food and Drug Law Institute (FDLI) ©2008
|
May/June 2008